Larisa V Kovtonyuk (Larisa Kovtonyuk)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Immune Response

Hematopoietic Stem Cell

High Throughput

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
Veronika Lysenko, Patrick M Schürch, Selma Tuzlak, Nicole Wildner-Verhey van Wijk, Larisa V Kovtonyuk, Burkhard Becher, Markus Gabriel Manz, Stefanie Kreutmair, Alexandre P A Theocharides
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model. Leukemia (2023)
C Matthias Wilk, Larisa V Kovtonyuk, Markus Gabriel Manz
Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels. Blood advances 6 (15) (2022)
Stephan Isringhausen, YeVin Mun, Larisa V Kovtonyuk, Nike J Kräutler, Ute Suessbier, Alvaro Gomariz, Gianluca Spaltro, Patrick Michael Helbling, Hui Chyn Wong, Takashi Nagasawa, Markus Gabriel Manz, Annette Oxenius, Cesar Nombela-Arrieta
Chronic viral infections persistently alter marrow stroma and impair hematopoietic stem cell fitness. The Journal of experimental medicine 218 (12) (2021)